Pharmaceutical naming is extremely complex, given regulatory and legal constraints and parameters. The world’s most innovative and respected pharmaceutical companies continuously trust our brand creation agency and name safety partner, SafeMark, for proprietary, non-proprietary, and clinical trial verbal and visual branding. When you partner with us, you’re in great company, and joining a team with more than 220 years of combined leadership expertise in the pharmaceutical and healthcare sector.
WHY WE’RE DIFFERENT
DECADES OF INDUSTRY EXPERTISE
With 200,000 drugs on the market and more than 1.3 million registered trademarks in Class 5, pharmaceutical naming has never been more elaborate. The difference of one letter could lead to a drug being mistakenly prescribed, resulting in patient harm, or even death. Our senior leadership team, with decades of pharmaceutical branding experience to their name, works directly on your project to navigate these hurdles and deliver creative, screened, and tested names and confidence.
NO NAMING DATABASES
Your brand isn’t cookie cutter, and we don’t utilize a previously concepted bank of names to pull from for your project. Our global team of brand naming experts approaches each project individually, to develop original, inventive ideas that are specific to you, your brand, your drug attributes, and your goals. We’re all about recycling, but not for the work we do for clients.
TRADEMARK PARALEGALS ON STAFF
Our team includes trademark paralegals who screen and vet each candidate we show to you. We want to make sure we are only putting viable options in front of your team and take the necessary steps up front to do so.
TRADEMARK & POCA ANALYSIS
Our paralegals employ a combination of tools that include 268 international trademark databases, along with Pharma-In-Use Legal Prescreen (Corsearch®) and Common-Law Prescreen. Name candidates are also screened with the FDA POCA system to assure that no presented options exceed a 75% threshold in combined Phonetic and Orthographic score.
GLOBAL LINGUISTICS EVALUATION
The world will likely be your stage, and making sure your brand is received well in every market you’ll enter is our top priority. This thorough evaluation is conducted in your 10 identified primary language markets, with in-country, native language-speaking professionals, to ensure the names communicate the correct messaging across all geographic regions.
UNPARALLELED NAME SAFETY TESTING
Our sister brand, SafeMark, is the industry-leader in robust and comprehensive regulatory consulting, safety testing, and package and label services for the pharmaceutical and healthcare industries.
IN IT UNTIL YOU WIN IT
We guarantee a partnership until the name is approved for your compound. Period.
A track record of success
We’ve created more than 122 healthcare brand identities…and we’re not looking to slow down any time soon. We want to be your pharmaceutical branding agency.
PHARMACEUTICAL BRANDING SUCCESS STORIES
WE’RE BUILDING BOLD BRANDS FOR OUR PHARMACEUTICAL PARTNERS
Pharma Branding Knowledge:
Should I Judge a Pill By Its Color?
Does a medication’s design, in this case, color, make a difference? What would the world look like without “that pink stuff” to aid with a bellyache? Within the pharmaceutical space, colors not only signify the
Research Style – Self-Administered Questionnaires (SAQs)
There are several beneficial market research styles for gathering data or information. One of the most convenient and user-friendly of these are online, self-administered questionnaires. Why? An online, self-administered questionnaire (SAQ) is a valuable method
The Importance Of Name Safety Testing Tools In Brand Development
Our goal is to provide our pharmaceutical clients with a simple, sequenced, transparent, and standardized approach to name safety testing. Our safety testing process is designed to adhere to the guidelines for proprietary (invented) name reviews by global health
Are We Running Out of Trademarks?
Assess the current trademark landscape as you finalize your initiatives for the remainder of the year. In this article, we’ll examine an important trademark trend that could impact your name development strategies. Running Out
Nonprescription Brand Names – Q&A
In December 2020, the FDA released “Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products Guidance for Industry,” a draft guidance for industry to consider when developing and evaluating a brand name for
Medication Profile – ISMP High Alert Medications
As always, we want to be a reliable industry source for the most recent and relevant branding and regulatory topics. The Institute for Safe Medication Practices (ISMP) updated the list of High Alert Medications in
[8:49 AM] Jacob Lindgren